Literature DB >> 15715625

Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII.

V G Nielsen1, B M Cohen, E Cohen.   

Abstract

BACKGROUND: Thrombelastography (TEG) is used to assess coagulopathy. However, a comprehensive characterization of the effects of specific coagulation factor deficiencies and mode of activation on TEG data does not exist.
METHODS: Thrombelastography was performed for 15 min with control plasma and plasmas deficient (<1% activity) in Factors II, V, VII, VIII, IX, X, XI, XII, or XIII activated with celite (0.28 mg ml(-1)) or tissue factor (TF, 0.1%) (n = 6 per condition). Additional fibrinogen concentration activity (75-345 mg dl(-1)) and Factor II, VII, X and XII activity-response relationships (1%, 6.25%, 12.5%, 25%, 50% and 100% activity) were obtained (n = 8 per condition). Thrombelastography parameters included reaction time (R), angle (alpha), and clot strength (A, amplitude; G, elastic modulus).
RESULTS: Celite activation of FXII-deficient plasma, TF activation of FVII-deficient and FX-deficient plasma, and celite or TF activation of FII-deficient plasma resulted in an almost undetectable clot. Compared to control values, celite activation of plasmas deficient in FXI, FIX and FVIII resulted in prolonged R and decreased alpha values, whereas TF activation resulted in decreased alpha values. Celite and TF activation of FV-deficient plasma resulted in prolonged R and decreased alpha values, whereas FXIII-deficient plasma had decreased alpha, A and G-values compared to control values.
CONCLUSIONS: The fundamental finding of this study is that coagulation factor deficiencies affect TEG parameters in both a factor-dependent and activation-dependent fashion. Utilizing both celite and TF activation improves the diagnostic power of TEG. Based on such TEG data, more targeted administration of blood products could potentially help improve perioperative hemostatic outcomes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15715625     DOI: 10.1111/j.1399-6576.2005.00602.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  26 in total

1.  Clotting factor deficiency in early trauma-associated coagulopathy.

Authors:  Sandro B Rizoli; Sandro Scarpelini; Jeannie Callum; Bartolomeu Nascimento; Kenneth G Mann; Ruxandra Pinto; Jan Jansen; Homer C Tien
Journal:  J Trauma       Date:  2011-11

2.  Fibrin clot structure and mechanics associated with specific oxidation of methionine residues in fibrinogen.

Authors:  Katie M Weigandt; Nathan White; Dominic Chung; Erica Ellingson; Yi Wang; Xiaoyun Fu; Danilo C Pozzo
Journal:  Biophys J       Date:  2012-12-05       Impact factor: 4.033

3.  Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists.

Authors:  Francesco Franchi; Jafri Syed Hammad; Fabiana Rollini; Antonio Tello-Montoliu; Ronakkumar Patel; Andrew Darlington; Dale F Kraemer; Jung Rae Cho; Christopher DeGroat; Mona Bhatti; Mohamad Taha; Dominick J Angiolillo
Journal:  J Thromb Thrombolysis       Date:  2015-07       Impact factor: 2.300

Review 4.  Management of Trauma-Induced Coagulopathy with Thrombelastography.

Authors:  Eduardo Gonzalez; Ernest E Moore; Hunter B Moore
Journal:  Crit Care Clin       Date:  2017-01       Impact factor: 3.598

5.  Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage.

Authors:  Arne Lauer; Flor A Cianchetti; Elizabeth M Van Cott; Frieder Schlunk; Elena Schulz; Waltraud Pfeilschifter; Helmuth Steinmetz; Chris B Schaffer; Eng H Lo; Christian Foerch
Journal:  Circulation       Date:  2011-09-12       Impact factor: 29.690

6.  A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding.

Authors:  Rami A Al-Horani; Elsamani I Abdelfadiel; Daniel K Afosah; Shravan Morla; Jyothi C Sistla; Bassem Mohammed; Erika J Martin; Masahiro Sakagami; Donald F Brophy; Umesh R Desai
Journal:  J Thromb Haemost       Date:  2019-09-10       Impact factor: 5.824

7.  Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury.

Authors:  Oliver Grottke; Till Braunschweig; Dietrich Henzler; Mark Coburn; Rene Tolba; Rolf Rossaint
Journal:  Crit Care       Date:  2010-04-14       Impact factor: 9.097

8.  Role of platelets, neutrophils, and factor XII in spontaneous venous thrombosis in mice.

Authors:  Marco Heestermans; Salam Salloum-Asfar; Daniela Salvatori; El Houari Laghmani; Brenda M Luken; Sacha S Zeerleder; Henri M H Spronk; Suzanne J Korporaal; Gerry T M Wagenaar; Pieter H Reitsma; Bart J M van Vlijmen
Journal:  Blood       Date:  2016-03-01       Impact factor: 22.113

Review 9.  Fibrinogen concentrate in bleeding patients.

Authors:  Anne Wikkelsø; Jens Lunde; Mathias Johansen; Jakob Stensballe; Jørn Wetterslev; Ann Merete Møller; Arash Afshari
Journal:  Cochrane Database Syst Rev       Date:  2013-08-29

10.  Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography.

Authors:  Sae-Yeon Won; Frieder Schlunk; Julien Dinkel; Hulya Karatas; Wendy Leung; Kazuhide Hayakawa; Arne Lauer; Helmuth Steinmetz; Eng H Lo; Christian Foerch; Rajiv Gupta
Journal:  Stroke       Date:  2013-08-06       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.